AstraZeneca
The Evidence Lead BBU & OBU at AstraZeneca leads real-world evidence generation across key portfolios to inform clinical practice, product strategy, and market access decisions. This role involves collaborating with clinical, medical, and commercial teams to design studies, manage vendors, and prepare regulatory dossiers while mentoring staff and ensuring compliance.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
46% below the average for this role
Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology
GSK plc
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Real-World Evidence (RWE) Scientific Lead
sanofi us
Senior Manager, Oncology
Pfizer
Senior Real World Evidence Expert
UCB
Senior Real World Evidence Expert
UCB